Samsara BioCapital, LLC has disclosed 42 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2024-09-30. The current portfolio value is calculated to be $520.00 Mil. The turnover rate is 8%.
In Samsara BioCapital, LLC's current portfolio as of 2024-09-30, the top 5 holdings are
Cargo Therapeutics Inc (CRGX), Mineralys Therapeutics Inc (MLYS), Scholar Rock Holding Corp (SRRK), Neurogene Inc (NGNE), Alumis Inc (ALMS), not including call and put options.
Samsara BioCapital, LLC did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Samsara BioCapital, LLC, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Samsara BioCapital, LLC, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Samsara BioCapital, LLC.